Chondroitin sulphate and mast cell alterations in benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCA)

被引：0
|
作者：
Magkou, C [1 ]
Koukoumides, C [1 ]
Sitaras, NM [1 ]
机构：
[1] Univ Athens, Sch Med, Dept Expt Pharmacol, GR-10679 Athens, Greece
来源：
TISSUE ANTIGENS | 2004年 / 64卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [41] Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH)
    Ventura, S.
    Oliver, V. L.
    White, C. W.
    Xie, J. H.
    Haynes, J. M.
    Exintaris, B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (05) : 891 - 907
  • [42] Patients with benign prostatic hyperplasia (BPH): Medical therapy or surgery?
    DiSilverio, F
    Sciarra, A
    DEramo, G
    Casale, P
    DiNicola, S
    Buscarini, M
    DiChiro, C
    Loreto, A
    BPH FROM MOLECULAR BIOLOGY TO PATIENT RELIEF, 1996, : 89 - 96
  • [43] Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH)
    Bach, D
    Schmitt, M
    Ebeling, L
    PHYTOMEDICINE, 1997, 3 (04) : 309 - 313
  • [44] A Review of Laser Treatment for Symptomatic BPH (Benign Prostatic Hyperplasia)
    Nair, Shiva Madhwan
    Pimentel, Marie Adrianne
    Gilling, Peter John
    CURRENT UROLOGY REPORTS, 2016, 17 (06)
  • [45] Screening for pathogenic microorganisms in advanced benign prostatic hyperplasia (BPH)
    Mitteregger, Dieter
    Aberle, Stephen W.
    Makristathis, Athanasios
    Walochnik, Julia
    Schwarz, Sarah M.
    Kramer, Gero
    Marberger, Michael
    JOURNAL OF UROLOGY, 2007, 177 (04): : 448 - 449
  • [46] Prostatic stents for benign prostatic hyperplasia
    Klein, LT
    Kaplan, SA
    JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS, 1997, 7 (01) : 101 - 114
  • [47] Prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH): efficacy and safety at 1 year
    Chiu, P. K.
    Kwok, K. Y.
    Yee, C. H.
    Teoh, J. Y.
    Sy, L. I.
    Kwok, S. W.
    Cho, C. C. M.
    Hung, E. H. Y.
    Ng, C. F.
    Yu, S. C. H.
    BJU INTERNATIONAL, 2019, 123 : 5 - 5
  • [48] DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma
    Werely, CJ
    Heyns, CF
    VanVelden, DJJ
    VanHelden, PD
    GENES CHROMOSOMES & CANCER, 1996, 17 (01): : 31 - 36
  • [49] EXPRESSION OF BONE MORPHOGENETIC PROTEINS IN HUMAN PROSTATIC ADENOCARCINOMA AND BENIGN PROSTATIC HYPERPLASIA
    BENTLEY, H
    HAMDY, FC
    HART, KA
    SEID, JM
    WILLIAMS, JL
    JOHNSTONE, D
    RUSSELL, RGG
    BRITISH JOURNAL OF CANCER, 1992, 66 (06) : 1159 - 1163
  • [50] TUMOR-SPECIFIC IMMUNITY IN PATIENTS WITH PROSTATIC ADENOCARCINOMA OR BENIGN PROSTATIC HYPERPLASIA
    BRANNEN, GE
    COFFEY, DS
    CANCER TREATMENT REPORTS, 1977, 61 (02): : 211 - 216
12345